Vassallo, Chiara, Beatrice Canali, Francesca Fiorentino, Paolo Morelli, Silvia Ripoli, and Laura Fioravanti. 2023. “Brentuximab Vedotin + AVD in CHL: Cost Impact on Adverse Events, Toxicity, Second Malignancies, End-of-Life and Subsequent Lines of Therapy in Italy”. AboutOpen 10 (1):103-9. https://doi.org/10.33393/ao.2023.2609.